Improved Hemoglobin Status and Reduced Menstrual Blood Loss among Female Carriers of Factor V Leiden – An Evolutionary Advantage?

• References

• 1 Bertina RM, Koelemann BP, Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein. C. Nature 1994; 369 3475 64-7.
• 2 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism charactedrized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90 (Suppl. 03) 1004-8.
• 3 Dahlbäck B. Blood coagulation. Lancet 2000; 355 9215 1627-32.
• 4 Högberg U, Broström G. The demography of maternal mortality-seven Swedish parishes in the 19th century. Int J Gynaecol Obstet 1985; 23 (Suppl. 06) 489-97.
• 5 Lindqvist PG, Svensson PJ, Marsal K, Grennert L, Lutherkort M, Dahlbäck B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.